Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gernot Zissel

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
The American Journal of Pathology|April 11, 2009
Essential role of osteopontin in smoking-related interstitial lung diseasesAntje Prasse, Mirjam Stahl, Guido Schulz, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2010
Extracellular adenosine triphosphate and chronic obstructive pulmonary diseaseMarek Lommatzsch, Sanja Cicko, Tobias Müller, et al.
Oncotarget|April 19, 2017
The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung diseaseTobias Müller, Susanne Fay, Rodolfo Paula Vieira, et al.
Respiratory Research|April 17, 2021
Analysis of single nucleotide polymorphisms in chronic beryllium diseaseBjörn C Frye, Karoline I Gaede, Cesare Saltini, et al.
American Journal of Respiratory Cell and Molecular Biology|May 29, 2010
P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysemaMonica Lucattelli, Sanja Cicko, Tobias Müller, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2011
Purinergic receptor type 6 contributes to airway inflammation and remodeling in experimental allergic airway inflammationRodolfo Paula Vieira, Tobias Müller, Melanie Grimm, et al.
Frontiers in Immunology|September 8, 2017
P2Y<sub>6</sub> Receptor Activation Promotes Inflammation and Tissue Remodeling in Pulmonary FibrosisTobias Müller, Susanne Fay, Rodolfo Paula Vieira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2010
Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysemaSanja Cicko, Monica Lucattelli, Tobias Müller, et al.
The European Respiratory Journal|September 1, 2012
Genome-wide association analysis reveals 12q13.3-q14.1 as new risk locus for sarcoidosisSylvia Hofmann, Annegret Fischer, Michael Nothnagel, et al.
Mbio|February 20, 2024
Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to <i>M. tuberculosis</i> infectionNatalie E Nieuwenhuizen, Geraldine Nouailles, Jayne S Sutherland, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
The American Journal of Pathology|April 11, 2009
Essential role of osteopontin in smoking-related interstitial lung diseasesAntje Prasse, Mirjam Stahl, Guido Schulz, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2010
Extracellular adenosine triphosphate and chronic obstructive pulmonary diseaseMarek Lommatzsch, Sanja Cicko, Tobias Müller, et al.
Oncotarget|April 19, 2017
The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung diseaseTobias Müller, Susanne Fay, Rodolfo Paula Vieira, et al.
Respiratory Research|April 17, 2021
Analysis of single nucleotide polymorphisms in chronic beryllium diseaseBjörn C Frye, Karoline I Gaede, Cesare Saltini, et al.
American Journal of Respiratory Cell and Molecular Biology|May 29, 2010
P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysemaMonica Lucattelli, Sanja Cicko, Tobias Müller, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2011
Purinergic receptor type 6 contributes to airway inflammation and remodeling in experimental allergic airway inflammationRodolfo Paula Vieira, Tobias Müller, Melanie Grimm, et al.
Frontiers in Immunology|September 8, 2017
P2Y<sub>6</sub> Receptor Activation Promotes Inflammation and Tissue Remodeling in Pulmonary FibrosisTobias Müller, Susanne Fay, Rodolfo Paula Vieira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2010
Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysemaSanja Cicko, Monica Lucattelli, Tobias Müller, et al.
The European Respiratory Journal|September 1, 2012
Genome-wide association analysis reveals 12q13.3-q14.1 as new risk locus for sarcoidosisSylvia Hofmann, Annegret Fischer, Michael Nothnagel, et al.
Mbio|February 20, 2024
Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to <i>M. tuberculosis</i> infectionNatalie E Nieuwenhuizen, Geraldine Nouailles, Jayne S Sutherland, et al.
Pageof 9